RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
6.64
+0.30 (4.73%)
Apr 2, 2026, 4:00 PM EDT - Market closed
RxSight Market Cap
RxSight has a market cap or net worth of $274.01 million as of April 2, 2026. Its market cap has decreased by -72.77% in one year.
Market Cap
274.01M
Enterprise Value
56.92M
1-Year Change
-72.77%
Ranking
Category
Stock Price
$6.64
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $274.01M, a decrease of -35.43%. That is a compound annual growth rate of -8.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 274.01M | -36.04% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viemed Healthcare | 371.74M |
| CapsoVision | 370.80M |
| Cerus | 357.44M |
| Standard BioTools | 354.15M |
| Delcath Systems | 334.61M |
| Senseonics Holdings | 288.39M |
| ClearPoint Neuro | 277.95M |
| TriSalus Life Sciences | 260.40M |